Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/46396
Campo DC Valoridioma
dc.contributor.authorBurmistrova, Olgaen_US
dc.contributor.authorPerdomo, Juanen_US
dc.contributor.authorSimões, M. Fátimaen_US
dc.contributor.authorRijo, Patriciaen_US
dc.contributor.authorQuintana, Joseen_US
dc.contributor.authorEstevez, Franciscoen_US
dc.contributor.otherSimoes, M. Fatima-
dc.contributor.otheriMed.ULisboa, NatProdChem-
dc.contributor.otheriMed.ULisboa, iMed.ULisboa-
dc.contributor.otherQuintana, Jose-
dc.contributor.otherEstevez, Francisco-
dc.contributor.otherRijo, Patricia Dias de Mendonca-
dc.contributor.otherDiaz, Perdomo-
dc.date.accessioned2018-11-23T04:12:37Z-
dc.date.available2018-11-23T04:12:37Z-
dc.date.issued2015en_US
dc.identifier.issn0944-7113en_US
dc.identifier.urihttp://hdl.handle.net/10553/46396-
dc.description.abstractBackground: Abietane diterpenes have attracted much attention because they display a wide range of biological activities, including antitumor activities. These compounds are the most diverse of the diterpenoids isolated from species of Plectranthus. Naturally occurring diterpene parvifloron D is the main phytochemical constituent of Plectranthus ecklonii. To examine the therapeutic potential of the plant, we evaluated whether parvifloron D displays cytotoxicity against human tumor cells.Methods: The cytotoxicity was analyzed by colorimetric 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay. Apoptosis was evaluated by fluorescent microscopy, transmission electron microscopy, flow cytometric analysis of annexin V-FITC and propidium iodide-stained cells and DNA fragmentation. Protein expression and processing and release of mitochondrial proteins were analyzed by Western blot. Caspase activity was determined using colorimetric substrates. The membrane potential and intracellular reactive oxygen species were detected by flow cytometry.Results: Parvifloron D displays strong cytotoxic properties against leukemia cells (HL-60, U-937, MOLT-3 and K-562) and in particular P-glycoprotein-overexpressing K-562/ADR cells, but has only weak cytotoxic effects on peripheral blood mononuclear cells (PBMCs). Overexpression of the protective mitochondrial proteins Bcl-2 and Bcl-x(L) did not confer resistance to parvifloron D-induced cytotoxicity. Growth inhibition of HL-60 cells that was triggered by parvifloron D was found to be caused by a rapid induction of apoptotic cell death. This apoptosis was prevented by the non-specific caspase inhibitor z-VAD-fmk, and by the selective caspase-9 inhibitor z-LEHD-fmk. Cell death induced by parvifloron D was found to be (i) associated with the dissipation of the mitochondrial membrane potential and the release of cytochrome c, (ii) amplified by inhibition of extracellular signal-regulated kinases (ERKs) 1/2 signaling and (iii) caused by a mechanism dependent on intracellular reactive oxygen species generation.Conclusion: Parvifloron D is a potent cytotoxic compount against several human tumor cells and also a fast and potent apoptotic inducer in leukemia cells.en_US
dc.languageengen_US
dc.relationEvaluación de Potenciales Compuestos Antileucémicos.en_US
dc.relation.ispartofPhytomedicineen_US
dc.sourcePhytomedicine[ISSN 0944-7113],v. 22 (11), p. 1009-1016en_US
dc.subject32 Ciencias médicasen_US
dc.subject320101 Oncologíaen_US
dc.subject.otherDeathen_US
dc.subject.otherActivationen_US
dc.subject.otherCaspasesen_US
dc.subject.otherCleavageen_US
dc.subject.otherOxygenen_US
dc.titleThe abietane diterpenoid parvifloron D from Plectranthus ecklonii is a potent apoptotic inducer in human leukemia cellsen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.phymed.2015.06.013en_US
dc.identifier.scopus84941565035-
dc.identifier.isi000362801400006-
dcterms.isPartOfPhytomedicine-
dcterms.sourcePhytomedicine[ISSN 0944-7113],v. 22 (11), p. 1009-1016-
dc.contributor.authorscopusid54396785700-
dc.contributor.authorscopusid55750901700-
dc.contributor.authorscopusid7102405767-
dc.contributor.authorscopusid8600601700-
dc.contributor.authorscopusid8681043500-
dc.contributor.authorscopusid7003810011-
dc.description.lastpage1016en_US
dc.description.firstpage1009en_US
dc.relation.volume22en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.identifier.wosWOS:000362801400006-
dc.contributor.daisngid4152189-
dc.contributor.daisngid32236859-
dc.contributor.daisngid2333322-
dc.contributor.daisngid1407382-
dc.contributor.daisngid631925-
dc.contributor.daisngid128315-
dc.contributor.daisngid384944-
dc.identifier.investigatorRIDK-1130-2012-
dc.identifier.investigatorRIDB-5387-2014-
dc.identifier.investigatorRIDC-6292-2014-
dc.identifier.investigatorRIDK-5709-2014-
dc.identifier.investigatorRIDK-5125-2014-
dc.identifier.investigatorRIDNo ID-
dc.identifier.investigatorRIDNo ID-
dc.description.numberofpages8en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Burmistrova, O-
dc.contributor.wosstandardWOS:Perdomo, J-
dc.contributor.wosstandardWOS:Simoes, MF-
dc.contributor.wosstandardWOS:Rijo, P-
dc.contributor.wosstandardWOS:Quintana, J-
dc.contributor.wosstandardWOS:Estevez, F-
dc.date.coverdateOctubre 2015en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sjr1,013
dc.description.jcr2,937
dc.description.sjrqQ1
dc.description.jcrqQ1
dc.description.scieSCIE
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.orcid0000-0002-0163-393X-
crisitem.author.orcid0000-0001-8225-4538-
crisitem.author.orcid0000-0002-9728-2774-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNamePerdomo Díaz, Juan-
crisitem.author.fullNameQuintana Aguiar, José Martín-
crisitem.author.fullNameEstévez Rosas, Francisco Jesús-
crisitem.project.principalinvestigatorEstévez Rosas, Francisco Jesús-
Colección:Artículos
Vista resumida

Citas SCOPUSTM   

34
actualizado el 15-dic-2024

Citas de WEB OF SCIENCETM
Citations

35
actualizado el 15-dic-2024

Visitas

74
actualizado el 17-ago-2024

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.